Ar H-5), 6.91 (4H, m, Ar ald H-5, Ar ald H-6), 6.59 (2H, d, J 6,
Ar H-4), 4.17 (4H, t, J 5, OCH2), 4.05 (4H, t, J 5, OCH2), 3.88
(4H, t, J 5, OCH2), 3.82 (4H, t, J 5, OCH2), 1.23 (9H, s, t-
butyl); dC (75 MHz, CDCl3) 31.0, 35.0, 67.4, 68.2, 69.8, 106.9,
111.0, 113.0, 121.0, 121.9, 125.0, 128.3, 129.7, 134.8, 136.1,
139.5, 152.6, 159.1, 161.3, 166.0, 190.5; m/z (ESI) 811 [(M þ
Na)1 requires 811.89], 789.33 [(M þ H)1 requires 789.91]; m/z
(EI) 788.3311 [M1 requires 788.3309].
ethanol (4 g, 23.7 mmol) was then added and the mixture was
refluxed for 5 days. The mixture was then cooled to room
temperature and filtered to remove potassium salts. The sol-
vent was then evaporated, and the residue was taked up in
EtOAc (100 ml), washed with HCl (dilute, 2 ꢀ 50 ml), water
(50 ml) and dried (Na2SO4). The solvent was then removed
in vacuo to yield 11 as a thick yellow oil (3.25 g, 40%); dH (300
MHz, d6-acetone) 9.64 (2H, s, NH), 8.29 (1H, t, J 1.5,
isophthal H–2), 8.15 (2H, d, J 1.5, isophthal H–4), 7.58 (2H, t,
J 2, Ar H-2), 7.36 (2H, d, J 8, Ar H-6), 7.21 (2H, t, J 8, Ar H-5),
6.68 (2H, d, J 8, Ar H-4), 4.12 (4H, t, J 5, OCH2), 3.83 (4H, t,
J 5, OCH2), 3.66–3.57 (8H, m, 2 ꢀ OCH2), 3.5 (8H, t, J 5, 2 ꢀ
OCH2), 3.1–2.9 (2H, bs, OH), 1.35 (9H, s, t-butyl); m/z (EI)
668.3313 [M1 required 668.3309], ca. 637 [(M-CH3O)1
requires 637.76], ca. 427 [(M-C12H18NO5]1 requires 427.52.
[2]-bis-{2,8,12,18-tetraethyl-3,7,13,17-tetramethyl-5,15
[2,2-{2-[2-[3-N,N0-(5-tert-butyl-1,3-benzenediamido)
phenyl]ethoxy]ethoxy}diphenyl] porphyrinato}-zinc(II)
[2]catenane (4)
and
{2,8,12,18-tetraethyl-3,7,13,17-tetramethyl-5,15[2,2-
{2-[2-[3-N,N0-(5-tert-butyl-1,3-benzenediamido)phenyl]
ethoxy] ethoxy}diphenyl]porphyrinato}-zinc(II) (3a)
5-tert-Butyl-N,N0-bis-[3-{2-[2-(2-nicotinoyloxy)ethoxy]
ethoxy}phenyl]-1,3-benzenediamide (5)
The extended diol 11 (200 mg, 0.299 mmol), nicotinic acid
(148 mg, 1.2 mmol), N-hydroxybenzotriazole (HOBT, 162 mg,
1.2 mmol) and 1-[(3-dimethylamino)propyl]-3-ethylcarbodii-
mide hydrochloride (EDC) (172 mg, 0.90 mmol) were dissolved
in CH2Cl2 (30 ml) before triethylamine (90.8 mg, 0.90 mmol)
was added via a syringe and the solution was stirred at room
temperature under nitrogen in the dark for 4 days. The solvent
was evaporated and the residue was taken up in 6 M HCl and
chloroform. The aqueous layer was separated and neutralised
with NaHCO3 (sat’d. aq.). The product was extracted with
chloroform, dried (Na2SO4) and the solvent removed to yield a
yellow/brown oil which was subjected to column chromato-
graphy using CH2Cl2, CH2Cl2/MeOH (1%) and CH2Cl2/
MeOH (5%) as the eluents to give the product 5 as a dark
yellow oil (150 mg, 57%); dH (300 MHz, CD2Cl2) 9.19 (2H, s,
NH), 8.86 (2H, s, H-py), 8.70 (2H, d, J 1, H-py), 8.27 (2H, d, J
2, H-py), 8.22 (1H, s, H-20), 8.09 (2H, s, H-40), 7.39–7.23 (8H,
m, H-600, H-500, H-200, H-py), 6.69 (2H, dm, J 8, H-400), 4.50
(8H, m, H-19, H-21), 4.09 (4H, m, H-20), 3.85 (12H, m, H-18,
H-17, H-16), 1.36 (9H, s, t-butyl); m/z (ESI-APCI) 879.4 [(M þ
H)1 requires 879.4].
The dialdehyde 1 (0.43 g, 0.54 mmol) and 3,30-diethyl-4,40-
dimethyl-2,20-dipyrrylmethane 2 (0.25 g, 1.1 mmol) were added
to a degassed solution of MeCN (50 ml). Trichloroacetic acid
(B20 mg) was then added and the mixture was left to stir (in
the dark, under N2) for 5 h. o-Chloroanil (0.75 g, 3 mmol) in
THF (20 ml) was added all at once and the mixture was taken
to dryness via rotary evaporator. The residue was run through
a plug of silica using EtOAc as the solvent followed by
insertion of zinc in the usual manner (excess Zn(OAc)2, MeOH/
CHCl3). The residue was then purified via silica column
chromatography using CH2Cl2, CH2Cl2/MeOH (1%) and
CH2Cl2/MeOH (5%) as the eluants to give two major frac-
tions. These fractions were recrystallised from acetone/MeOH
to yield bright purple solids 3 and 4.
4 (35 mg, 5%); dH (300 MHz, CD2Cl2/d3-MeOD) 10.24 (2H,
s, H-1), 8.63 (1H, s, H-20), 8.21 (2H, s, H-40), 7.75–7.69 (4H, m,
H-11, H-12), 7.36–7.28 (6H, m, H-600, H-13, H-14), 7.12 (2H, t, J
9, H-500), 7.05 (2H, m, Ar–H), 6.37 (2H, d, J 9, H-400), 4.24 (4H,
m, H-4), 4.20 (4H, m, H-16), 3.95 (4H, m, H-4), 3.26 (4H, m, H-
17), 2.97 (4H, m, H-19), 2.52 (12H, s, H-7), 2.25 (4H, m, H-18),
1.72 (12H, t, J 6, H-5), 1.50 (9H, s, t-butyl); m/z (ESI) 1269.7
[(M/2 þ H)1 requires 1269.5], 1207.6315 [(M/2ꢁZn þ H)1
requires 1207.6272]; m/z (FAB) 2538.6 [M1 requires 2537.066].
3a (75 mg, 11%), dH (300 MHz, CD2Cl2/d3-MeOD) 10.06
(2H, s, H-1), 8.06 (2H, s, H-40), 7.88 (1H, s, H-20), 7.75 (2H, t, J
6, H-12), 7.67 (2H, d, J 6, H-11), 7.49 (2H, d, J 9, H-600), 7.47–
7.29 (4H, m, H-13, H-14), 7.07 (2H, t, J 9, H-500), 6.49 (2H, m,
H-200), 6.37 (2H, d, J 9, H-400), 4.12 (4H, m, H-16), 3.95 (8H, m,
H-4), 3.22–3.16 (8H, m, H-19, H-17), 2.84 (4H, m, H-18), 2.52
(12H, s, H-7), 1.72 (12H, t, J 6, H-5), 1.33 (9H, s, t-butyl); dC
(75 MHz, CDCl3) 13.5, 17.5, 31.4, 34.1, 66.6, 69.6, 70.7, 96.1,
103.6, 110.9, 111.8, 113.6, 118.0, 121.0, 122.6, 127.5, 130.0,
134.6, 135.7, 138.7, 144.3, 158.8, 159.3; m/z (ESI) 1291.5285
[(M þ Na)1 requires 1291.5227], 1270 [(M þ H)1 requires
1269.5], ca. 1207 [(Mꢁ Zn þ 3H)1 requires 1207.1].
Pseudorotaxane (3b þ 5)
An equimolar mixture of porphyrin 3b and thread 5 were
combined in a NMR tube and allowed to reach equilibrium.
The porphyrin (Hp) and thread (Ht-) resonances were mon-
itored. dH (300 MHz, CD2Cl2) 10.23 (2H, s, Hp-1), 9.06 (2H, br
s, Ht-py), 8.53 (2H, br s, Ht-py), 8.47 (2H, br s, Ht-NH), 8.25
(2H, d, J 6, Ht-py), 8.20 (2H, s, Ht-20), 8.11 (2H, s, Ht-40), 8.06
(2H, s, Hp-40), 7.90 (1H, s, Hp-20), 7.80 (4H, t, J 6, Hp-11, Hp-
12), 7.68 (2H, d, J 9, Hp-600), 7.42–7.21 (12H, m, Hp-13, Hp-14,
Ht-200, Ht-500, Ht-600, Ht-py), 7.14 (2H, t, J 9, Hp-500), 6.71 (2H,
m, Hp-200), 6.65 (2H, d, J 9, Ht-400), 6.37 (2H, d, J 6, Hp-400),
4.49 (8H, m, Ht-19, Ht-20), 4.25 (4H, m, Hp-16), 4.06–4.03 (8H,
m, Ht-18, Ht–21), 3.85–3.77 (8H, m, Ht-16, Ht-17), 3.33 (8H,
m, Hp-17, Hp-19), 2.95 (4H, m, Hp-18), 2.6 (12H, s, Hp-7), 2.21
(12H, t, J 6, Hp-5), 1.30 (9H, s, Hp-t-butyl, Ht-t-butyl).
5-tert-Butyl-N,N0-bis-[3-{2-[2-(2-hydroxyethoxy) ethoxy]
ethoxy}phenyl]-1,3-benzenediamide (11)
Metalloporphyrin-stoppered rotaxane (7)
An equimolar mixture of strapped porphyrin 3b, thread 5 were
combined in an NMR tube. Two equivalents of ruthenium
carbonyl porphyrin 6 was added and the solution was allowed
to equilibrate (10 min). The porphyrin (Hp), thread (Htꢁ) and
ruthenium porphyrin (HRuPꢁ) resonances were monitored. dH
(300 MHz, CD2Cl2) 10.22 (2H, s, Hp-1), 8.97 (1H, br s, Ht-200),
8.72 (16H, s, HRuP-Ru), 8.45 (3H, br s, Ht-NH, Hp-20), 8.30
(1H, s, Ht-20), 8.23 (4H, m, Ht-40, Hp-40), 8.10 (18H, m, Ht-40,
The diol 8 (5 g, 12.4 mmol) and K2CO3 (7.95 g, 57.5 mmol)
were suspended in MeCN (dry, 200 ml) and heated, with
stirring, under N2 for 30 min. 2-[2-(2-Chloroethoxy)ethoxy]
H
RuP-Ru), 8.01 (2H, m, Hp-40), 7.90 (5H, m, Hp-20, Hp-11,
Hp-12), 7.82 (8H, s, HRuP-Ru), 7.67 (2H, d, J 6, Hp-600),
1448
N e w J . C h e m . , 2 0 0 4 , 2 8 , 1 4 4 3 – 1 4 4 9